Reply

Affiliations

Comment

Wesley T Beaulieu et al. Am J Ophthalmol. 2017 May.

. 2017 May:177:233.

doi: 10.1016/j.ajo.2017.02.010. Epub 2017 Mar 11.

No abstract available

Comment on

Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial.
Beaulieu WT, Bressler NM, Melia M, Owsley C, Mein CE, Gross JG, Jampol LM, Glassman AR; Diabetic Retinopathy Clinical Research Network. Beaulieu WT, et al. Am J Ophthalmol. 2016 Oct;170:206-213. doi: 10.1016/j.ajo.2016.08.008. Epub 2016 Aug 12. Am J Ophthalmol. 2016. PMID: 27523491 Free PMC article. Clinical Trial.
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial.
Desapriya E, Khoshpouri P, Al-Isa A. Desapriya E, et al. Am J Ophthalmol. 2017 May;177:232-233. doi: 10.1016/j.ajo.2017.01.035. Epub 2017 Mar 13. Am J Ophthalmol. 2017. PMID: 28302269 No abstract available.